Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

197.16
+1.650.84%
Post-market: 197.160.00000.00%17:00 EDT
Volume:865.42K
Turnover:170.39M
Market Cap:21.69B
PE:22.53
High:197.56
Open:196.67
Low:194.72
Close:195.51
52wk High:213.50
52wk Low:157.20
Shares:110.00M
Float Shares:110.00M
Volume Ratio:1.08
T/O Rate:0.79%
Dividend:3.20
Dividend Rate:1.62%
EPS(TTM):8.75
EPS(LYR):8.75
ROE:14.75%
ROA:6.20%
PB:3.02
PE(LYR):22.53

Loading ...

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 07

Quest Diagnostics Unveils New ctDNA MRD Data in Colorectal Cancer at ASCO GI 2026

Reuters
·
Jan 06

Quest Diagnostics and Corewell Health Form Diagnostic Lab Joint Venture in Michigan

Reuters
·
Jan 05

Quest Diagnostics Executives to Present Strategy at J.P. Morgan Healthcare Conference

Reuters
·
Dec 20, 2025

How Investors May Respond To Quest Diagnostics (DGX) Partnering With Octave On Nationwide MS Activity Testing

Simply Wall St.
·
Dec 16, 2025

What Quest Diagnostics (DGX)'s Octave MS Collaboration Means For Shareholders

Simply Wall St.
·
Dec 07, 2025

Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 02, 2025

Quest Diagnostics Partners with Octave Bioscience to Expand Access to MS Disease Activity Test

Reuters
·
Dec 01, 2025

Director’s Strategic Stock Sale at Quest Diagnostics!

TIPRANKS
·
Nov 29, 2025

Quest Diagnostics CEO and President James E. Davis Reports Disposal of Common Shares

Reuters
·
Nov 29, 2025

Director Vicky B. Gregg Reports Sale of Quest Diagnostics Common Shares

Reuters
·
Nov 29, 2025

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Nov 27, 2025

Quest Diagnostics (DGX) Gets a Hold from Barclays

TIPRANKS
·
Nov 24, 2025

A Look at Quest Diagnostics (DGX) Valuation Following Strong Q3 2025 Results and Upgraded Outlook

Simply Wall St.
·
Nov 23, 2025

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 22, 2025

Oracle Names Stephen Rusckowski to Board of Directors

Reuters
·
Nov 21, 2025

Quest Diagnostics (DGX) Receives a Buy from Mizuho Securities

TIPRANKS
·
Nov 20, 2025

Baird Adjusts Quest Diagnostics Price Target to $198 From $197, Maintains Neutral Rating

MT Newswires Live
·
Nov 18, 2025

DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 12, 2025

Quest Diagnostics Keeps Quarterly Dividend at $0.80 a Share, Payable Jan. 28, 2026, to Holders of Record Jan. 13

MT Newswires Live
·
Nov 12, 2025